CTRI/2023/02/049737已完成未知
To evaluate the Safety & Anti-dandruff efficacy of test products & test regimen in comparison to placebo & control on healthy human volunteers suffering from dandruff.
nilever Industries Pvt Ltd0 个研究点目标入组 346 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 346
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Female and male participants in the ratio of 2:1 in general good health.
- •2. Participants in the age group 18-45 years (both the ages inclusive).
- •3. Participants willing to give a written informed consent and agree to come for a regular follow up visit.
- •4. Participants with mild dandruff score of = 40 (adherent (ASFS) + non-adherent dandruff (non-ASFS))
- •5. Participants willing to abide by and comply with the study protocol.
- •6. Participants who have not participated in a similar investigation in the past three months.
- •7. Participants who agree to refrain from using hair dye / hair colour /henna during the study period.
- •8. Participants willing to refrain from any type of hair treatment like perming, straightening etc. during the study duration
- •9. Participants willing to refrain from any other anti-dandruff treatment/ products (including lotions/ home remedies/ oils/ serum/ mask) during the course of the study
- •10. Participants who agree to use test product & regimen (including hair oils).
排除标准
- •1. Participants who have undergone hair growth treatment within 3 months before screening into the study.
- •2. Participants having any active scalp disease which may interfere in the study – dermatologist’s judgement.
- •3. Participants with medicated / antidandruff oil will be excluded
- •4. Participants (male) having androgenic alopecia, male pattern baldness’ not be included in study.
- •5. Participants who have taken chemotherapy for cancer in the 6 months prior to start of the study or have a plan to do treatments during study.
- •6. Participants (females) who are pregnant or lactating
- •7. Participants who have had hair transplant.
- •8. A known history or present condition of allergic response/hypersensitivity to any cosmetic ingredients and pharmaceutical products.
- •9. Chronic illness which may influence the cutaneous state.
- •10. Participants participating in other similar cosmetic or therapeutic trial within last three months
- •11. Any history of underlying uncontrolled medical illness including diabetes mellitus, hypertension, HIV, hepatitis, severe anemia, serious disorder of heart and respiratory apparatus or any other serious medical illness.
- •12. Participants (males) who are having androgenic alopecia, male pattern baldness
研究者
相似试验
已完成
不适用
Hair Benefit Study For The Test ProductsCTRI/2021/09/036928nilever Industries Pvt Ltd207
尚未招募
2 期
Effect of the test product on dandruff controlCTRI/2023/09/057704Hindustan Unilever Limited
已完成
不适用
Hair Benefit Study For The Test RegimeCTRI/2021/09/036884nilever Industries Pvt Ltd205
已完成
不适用
Evaluation of anti-dandruff Efficacy of Test products On Healthy Human SubjectsCTRI/2017/05/008658ITC LIMITED ITC Life Sciences and Technology Centre47
尚未招募
Unknown
Anti-Dandruff Shampoo - EFFICACYCTRI/2023/03/050848GODREJ INDUSTRIES LTD.
